#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
CS
proLékaře.cz / Journals / Czecho-Slovak Pathology / 2023 - 4

Fat-poor spindle cell lipoma: a case report

Czech version

Authors: Jan Hrudka 1;  Jan Hojný 2;  Michaela Večeřová 3;  Zuzana Prouzová 1,2;  Radoslav Matěj 1,2,4
Authors‘ workplace: Ústav patologie 3. lékařské fakulty Univerzity Karlovy a Fakultní nemocnice Královské Vinohrady, Praha. 1;  Ústav patologie 1. lékařské fakulty Univerzity Karlovy a Všeobecné fakultní nemocnice, Praha. 2;  Klinika plastické chirurgie 3. lékařské fakulty Univerzity Karlovy a Fakultní nemocnice Královské Vinohrady, Praha. 3;  Ústav patologie a molekulární medicíny 3. lékařské fakulty Univerzity Karlovy a Fakultní Thomayerovy nemocnice, Praha. 4
Published in: Čes.-slov. Patol., 59, 2023, No. 4, p. 190-196
Category: Original Article

Overview

Spindle cell / pleomorphic lipoma is a relatively rare mesenchymal adipocytic tumor occurring typically in subcutaneous fat tissue in the posterior neck region in middle aged and elderly male. Microscopically, the tumor is usually well-circumscribed consisting of spindle shaped cells with myxoid stroma and variable amount of adult fat tissue. Entrapped collagen fibers and mast cells are constant finding. The lesion is characterized by positive CD34 immunohistochemistry. The tumor belongs to a family with chromosomes 13 and/or 16 deletion and loss of tumor suppressor gene RB1. Several histological variants including “fat-poor” spindle cell lipoma with minimal or absent fat cells may rarely occur. In this article we report a case of elderly man with a voluminous posterior neck tumor diagnosed as a fat-poor spindle cell lipoma based on histological examination, CD34-positivity and loss of Rb1 expression shown by immunohistochemistry. The diagnosis was confirmed by a molecular proof of RB1 deletion. The paper discusses a wide differential diagnosis of spindle cell myxoid CD34+ mesenchymal tumors.

Keywords:

spindle cell – pleomorphic – lipoma – myxoid – fat poor

Sources
  1. Povýšil C, Kodet R. Klasifikace nádorů. In: Povýšil C, Šteiner I. (Eds.) Obecná patologie. Galén, Praha, 2011: 203.
  2. Billings SD, Ud Din N. Spindle cell lipoma and pleomorphic lipoma. In: WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours. Lyon (France): International Agency for Research on Cancer; 2020 (WHO classification of tumours series, 5th ed.; vol. 3), 29-30.
  3. Enzinger FM, Harvey DA. Spindle cell lipoma. Cancer 1975; 36(5): 1852-1859.
  4. Shmookler BM, Enzinger FM. Pleomorphic lipoma: a benign tumor simulating liposarcoma. A clinicopathologic analysis of 48 cases. Cancer 1981; 47(1): 126-133.
  5. Ko JS, Daniels B, Emanuel PO, et al. Spindle Cell Lipomas in Women: A Report of 53 Cases. Am J Surg Pathol 2017; 41(9): 1267-1274.
  6. Fletcher CD, Martin-Bates E. Spindle cell lipoma: a clinicopathological study with some original observations. Histopathology 1987; 11(8): 803-817.
  7. Fletcher CD, Akerman M, Dal Cin P, et al. Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group. Am J Pathol 1996; 148(2): 623-630.
  8. Dal Cin P, Sciot R, Polito P, et al. Lesions of 13q may occur independently of deletion of 16q in spindle cell/pleomorphic lipomas. Histopathology 1997; 31(3): 222-225.
  9. Dahlén A, Debiec-Rychter M, Pedeutour F, et al. Clustering of deletions on chromosome 13 in benign and low-malignant lipomatous tumors. Int J Cancer 2003; 103(5): 616-623.
  10. Panagopoulos I, Gorunova L, Lund-Iversen M, et al. Cytogenetics of Spindle Cell/ Pleomorphic Lipomas: Karyotyping and FISH Analysis of 31 Tumors. Cancer Genomics Proteomics 2018; 15(3): 193-200.
  11. Michal M, Kazakov DV, Hadravský L, et al. Lipoblasts in spindle cell and pleomorphic lipomas: a close scrutiny. Hum Pathol 2017; 65: 140-146.
  12. Suster S, Fisher C. Immunoreactivity for the human hematopoietic progenitor cell antigen (CD34) in lipomatous tumors. Am J Surg Pathol 1997; 21(2): 195-200.
  13. Templeton SF, Solomon AR Jr. Spindle cell lipoma is strongly CD34 positive. An immunohistochemical study. J Cutan Pathol 1996; 23(6): 546-550.
  14. Tang LH, Lao QY, Yu L, Wang J. Spindle cell lipoma and pleomorphic lipoma: a clinicopathologic analysis of 65 cases. Zhonghua Bing Li Xue Za Zhi 2018; 47(4): 263-268.
  15. Chen BJ, Mariño-Enríquez A, Fletcher CD, Hornick JL. Loss of retinoblastoma protein expression in spindle cell/pleomorphic lipomas and cytogenetically related tumors: an immunohistochemical study with diagnostic implications. Am J Surg Pathol 2012; 36(8): 1119-1128.
  16. Billings SD, Folpe AL. Diagnostically challenging spindle cell lipomas: a report of 34 „low-fat“ and „fat-free“ variants. Am J Dermatopathol 2007; 29(5): 437-442.
  17. Sachdeva MP, Goldblum JR, Rubin BP, Billings SD. Low-fat and fat-free pleomorphic lipomas: a diagnostic challenge. Am J Dermatopathol 2009; 31(5): 423-426.
  18. Karim RZ, McCarthy SW, Palmer AA, Bonar SF, Scolyer RA. Intramuscular dendritic fibromyxolipoma: myxoid variant of spindle cell lipoma? Pathol Int 2003; 53(4): 252-258.
  19. Wong YP, Chia WK, Low SF, Mohamed-Haflah NH, Sharifah NA. Dendritic fibromyxolipoma: a variant of spindle cell lipoma with extensive myxoid change, with cytogenetic evidence. Pathol Int 2014; 64(7): 346-351.
  20. Liu S, Wang X, Lei B, et al. Dendritic fibromyxolipoma in the latissimus dorsi: a case report and review of the literature. Int J Clin Exp Pathol 2015; 8(7): 8650-8654.
  21. Liu H, Hei S, Wang J, Zhang Q, Yu X, Chen H. Dendritic fibromyxolipoma: A case report.Mol Clin Oncol 2021; 14(1): 7.
  22. Lane KL, Shannon RJ, Weiss SW. Hyalinizing spindle cell tumor with giant rosettes: a distinctive tumor closely resembling low-grade fibromyxoid sarcoma. Am J Surg Pathol 1997; 21(12): 1481-1488.
  23. Hušek K, Janíček P, Jelínek O. Nízce maligní fibromyxoidní sarkom. Cesk Patol 1998; 34(4):139-41.
  24. Cowan ML, Thompson LD, Leon ME, Bishop JA. Low-Grade Fibromyxoid Sarcoma of the Head and Neck: A Clinicopathologic Series and Review of the Literature. Head Neck Pathol 2016; 10(2): 161-166.
  25. Doyle LA, Möller E, Dal Cin P, Fletcher CD, Mertens F, Hornick JL. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma. Am J Surg Pathol 2011; 35(5): 733-741.
  26. Gjorgova Gjeorgjievski S, Fritchie K, Thangaiah JJ, Folpe AL, Din NU. Head and Neck Low-Grade Fibromyxoid Sarcoma: A Clinicopathologic Study of 15 Cases. Head Neck Pathol 2022; 16(2): 434-443.
  27. Panagopoulos I, Storlazzi CT, Fletcher CD, et al. The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma. Genes Chromosomes Cancer 2004; 40(3): 218-228.
  28. Lau PP, Lui PC, Lau GT, Yau DT, Cheung ET, Chan JK. EWSR1-CREB3L1 gene fusion: a novel alternative molecular aberration of lowgrade fibromyxoid sarcoma. Am J Surg Pathol 2013; 37(5): 734-738.
  29. Smith SC, Poznanski AA, Fullen DR, et al. CD34-positive superficial myxofibrosarcoma: a potential diagnostic pitfall. J Cutan Pathol 2013; 40(7): 639-645.
  30. Shmookler BM, Enzinger FM, Weiss SM. Giant cell fibroblastoma. A juvenile form of dermatofibrosarcoma protuberans. Cancer 1989; 64(10): 2154-2161.
  31. Hrudka J, Hojný J, Leamerová E, Matěj R. Obrovskobuněčný fibroblastom: kazuistika. Cesk Patol 2022; 58(3): 161-165.
  32. Simon MP, Pedeutour F, Sirvent N, et al. Deregulation of the platelet derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Nat Genet 1997; 15(1): 95-98.
  33. Doyle LA, Vivero M, Fletcher CD, Mertens F, Hornick JL. Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics. Mod Pathol 2014; 27(3): 390-395.
  34. Yoshida A, Tsuta K, Ohno M, et al. STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors. Am J Surg Pathol 2014; 38(4): 552-559.
  35. Ouladan S, Trautmann M, Orouji E, et al. Differential diagnosis of solitary fibrous tumors: A study of 454 soft tissue tumors indicating the diagnostic value of nuclear STAT6 relocation and ALDH1 expression combined with in situ proximity ligation assay. Int J Oncol 2015; 46(6): 2595-2605.
  36. Chmielecki J, Crago AM, Rosenberg M, et al. Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat Genet 2013; 45(2): 131-132.
  37. Robinson DR, Wu YM, Kalyana-Sundaram S, et al. Identification of recurrent NAB2STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. Nat Genet 2013; 45(2): 180-185.
  38. Dagrada GP, Spagnuolo RD, Mauro V, et al. Solitary fibrous tumors: loss of chimeric protein expression and genomic instability mark dedifferentiation. Mod Pathol 2015; 28(8):1074-1083.
  39. McMenamin ME, Fletcher CD. Mammary-type myofibroblastoma of soft tissue: a tumor closely related to spindle cell lipoma. Am J Surg Pathol 2001; 25(8): 1022-1029.
  40. Magro G, Righi A, Casorzo L, et al. Mammary and vaginal myofibroblastomas are genetically related lesions: fluorescence in situ hybridization analysis shows deletion of 13q14 region. Hum Pathol 2012; 43(11): 1887-1893.
  41. Howitt BE, Fletcher CD. Mammary-type Myofibroblastoma: Clinicopathologic Characterization in a Series of 143 Cases. Am J Surg Pathol 2016; 40(3): 361-367.
  42. Flucke U, van Krieken JH, Mentzel T. Cellular angiofibroma: analysis of 25 cases emphasizing its relationship to spindle cell lipoma and mammary-type myofibroblastoma. Mod Pathol 2011; 24(1): 82-89.
  43. Agaimy A, Michal M, Giedl J, et al. Superficial acral fibromyxoma: clinicopathological, immunohistochemical, and molecular study of 11 cases highlighting frequent Rb1 loss/ deletions. Hum Pathol 2017; 60: 192-198.
  44. Cullen D, Díaz Recuero JL, Cullen R, et al. Superficial Acral Fibromyxoma: Report of 13 Cases With New Immunohistochemical Findings. Am J Dermatopathol 2017; 39(1): 14-22.
  45. Libbrecht S, Van Dorpe J, Creytens D. The Rapidly Expanding Group of RB1-Deleted Soft Tissue Tumors: An Updated Review. Diagnostics (Basel) 2021; 11(3): 430.
  46. Downes KA, Goldblum JR, Montgomery EA, Fisher C. Pleomorphic liposarcoma: a clinicopathologic analysis of 19 cases. Mod Pathol 2001; 14(3): 179-184.
  47. Naber U, Friedrich RE, Glatzel M, Mautner VF, Hagel C. Podoplanin and CD34 in peripheral nerve sheath tumours: focus on neurofibromatosis 1-associated atypical neurofibroma. J Neurooncol 2011; 103(2): 239-245.
  48. Luis PP, Quiñonez E, Nogales FF, McCluggage WG. Lipomatous variant of angiomyofibroblastoma involving the vulva: report of 3 cases of an extremely rare neoplasm with discussion of the differential diagnosis. Int J Gynecol Pathol 2015; 34(2): 204-207.
  49. Fletcher CDM. Angiomyofibroblastoma. In: WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours. Lyon (France): International Agency for Research on Cancer; 2020 (WHO classification of tumours series, 5th ed.; vol. 3), 78-79.
  50. Boyraz B, Tajiri R, Alwaqfi RR, et al. Vulvar angiomyofibroblastoma is molecularly defined by recurrent MTG1-CYP2E1 fusions. Histopathology 2022; 81(6): 841-846.
  51. Tajiri R, Shiba E, Iwamura R, et al. Potential pathogenetic link between angiomyofibroblastoma and superficial myofibroblastoma in the female lower genital tract based on a novel MTG1-CYP2E1 fusion. Mod Pathol 2021; 34(12): 2222-2228.
  52. Mariño-Enríquez A, Fletcher CD. Angiofibroma of soft tissue: clinicopathologic characterization of a distinctive benign fibrovascular neoplasm in a series of 37 cases. Am J Surg Pathol 2012; 36(4): 500-508.
  53. Bekers EM, Groenen PJTA, Verdijk MAJ, et al. Soft tissue angiofibroma: Clinicopathologic, immunohistochemical and molecular analysis of 14 cases. Genes Chromosomes Cancer 2017; 56(10): 750-757.
  54. Balachandran K, Allen PW, MacCormac LB. Nuchal fibroma. A clinicopathological study of nine cases. Am J Surg Pathol 1995; 19(3): 313-317.
  55. Shek TW, Chan AC, Ma L. Extranuchal nuchal fibroma. Am J Surg Pathol 1996; 20(7): 902-903.
  56. Rekhi B, Folpe AL, Yu L. Superficial CD34-positive fibroblastic tumour. In: WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours. Lyon (France): International Agency for Research on Cancer; 2020 (WHO classification of tumours series, 5th ed.; vol. 3), 114-115.
  57. Carter JM, Weiss SW, Linos K, DiCaudo DJ, Folpe AL. Superficial CD34-positive fibroblastic tumor: report of 18 cases of a distinctive low-grade mesenchymal neoplasm of intermediate (borderline) malignancy. Mod Pathol 2014; 27(2): 294-302.
  58. Anderson WJ, Mertens F, Mariño-Enríquez A, Hornick JL, Fletcher CDM. Superficial CD34-Positive Fibroblastic Tumor: A Clinicopathologic, Immunohistochemical, and Molecular Study of 59 Cases. Am J Surg Pathol 2022; 46(10): 1329-1339.
  59. Puls F, Carter JM, Pillay N, et al. Overlapping morphological, immunohistochemical and genetic features of superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor. Mod Pathol 2022; 35(6): 767-776.
  60. Perret R, Michal M, Carr RA, et al. Superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases. Histopathology 2021; 79(5): 810-825.
  61. Lao IW, Yu L, Wang J. Superficial CD34-positive fibroblastic tumour: a clinicopathological and immunohistochemical study of an additional series. Histopathology 2017; 70(3):394-401.
Labels
Anatomical pathology Forensic medical examiner Toxicology
EDITORIAL
INTERVIEW
MONITOR
The role of flow cytometry in the diagnostics of pediatric haematologic and immunologic diseases
Flow cytometry immunophenotyping of the bone marrow samples for the diagnosis of hematologic neoplasms
The role of flow cytometry in the investigation of lymph node and extranodal lymphatic tissue specimen
Composite follicular lymphoma and in situ mantle cell neoplasia of lymph node: identification based on flow cytometry investigation
Post-mortem examination of cases of sudden cardiac death. The Czech experience and the possibility of involving pathologists in a multidisciplinary process
Article was published in

Czecho-Slovak Pathology

Issue 4
2023 Issue 4
Most read in this issue
Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#